LUPINNSELupin Limited· PharmaceuticalsMediumNeutral
Announced Tue, 26 Aug · 15:34 IST

Lupin Limited has informed the Exchange regarding Notice of Postal Ballot dated August 20, 2025, along with explanatory statement.

Board & Shareholder Meetings View source PDF

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lupin has issued a Postal Ballot Notice dated August 20, 2025, seeking shareholder approval through remote e-voting (from August 27 to September 25, 2025) for two items. The first is the re-appointment of Mr. Mark D. McDade as an Independent Director for a second 5-year term starting January 28, 2026, to January 27, 2031 — he will turn 75 during this term, which is why a Special Resolution is required. The second is a revision in the remuneration of Managing Director Mr. Nilesh D. Gupta effective October 1, 2025, for the remainder of his term ending August 31, 2028. The proposed revised pay includes a Basic Salary of ₹7.2 crore per annum, other allowances and flexi benefits of about ₹2.51 crore per annum, retirals as per company policy, and an annual performance incentive of up to 100% of fixed CTC (raised from the earlier 50% cap). Lupin justifies the revision by pointing to strong performance under Mr. Gupta — standalone revenue grew 53.9% (from ₹11,025.7 crore in FY20 to ₹16,967.5 crore in FY25) and net profit surged 446.1% (from ₹727.5 crore to ₹3,972.9 crore) — and a Deloitte peer benchmarking that places his current total pay in the bottom 10% of comparable pharma CEOs (Dr. Reddy's, Cipla, Zydus, Glenmark, Torrent, Alkem, Jubilant).

Likely market impact

The remuneration revision modestly raises the MD's fixed pay and doubles the performance incentive ceiling, which is shareholder-friendly as it links a larger share of pay to performance, but it will increase Lupin's managerial compensation cost. Re-appointment of the Independent Director is largely procedural and signals continuity in board oversight. No major negative or positive stock catalyst is expected; results of the postal ballot will be announced by September 29, 2025.